Bharat Immunolog

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE994B01014
  • NSEID:
  • BSEID: 524663
INR
17.08
-0.33 (-1.9%)
BSENSE

Jan 21

BSE+NSE Vol: 28.05 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 936506,
    "name": "Bharat Immunolog",
    "stock_name": "Bharat Immunolog",
    "full_name": "Bharat Immunological & Biological Corporation Ltd",
    "name_url": "stocks-analysis/bharat-immunolog",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "17.08",
    "chg": -0.33,
    "chgp": "-1.9%",
    "dir": -1,
    "prev_price": "17.41",
    "mcapval": "74.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524663,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE994B01014",
    "curr_date": "Jan 21",
    "curr_time": "",
    "bse_nse_vol": "28.05 k",
    "exc_status": "Active",
    "traded_date": "Jan 21, 2026",
    "traded_date_str": "2026 01 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bharat-immunolog-936506-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Bharat Immunological & Biological Corporation Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bharat-immunological-biological-corporation-ltd-fallingrising-3799185",
        "imagepath": "",
        "date": "2026-01-22 01:20:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>The stock has experienced a notable decline over recent periods, with a one-week loss of 7.22%, significantly underperforming the Sensex’s modest 1.77% drop. Over the past month, the stock fell 8.17%, more than double the benchmark’s 3.56% decline. Year-to-date, the stock has dropped 14.90%, while the Sensex has only declined 3.89%. This trend extends over longer horizons, with the stock losing 34.88% in the last year compared to the Sensex’s 8.01% gain, and a 39.11% decline over three years against a 35.12% rise in the benchmark. The five-year performance is even more stark, with the stock plunging 74.86% while the Sensex surged 65.06%.</p>\n<p>On 21-Jan, the stock hit a new 52-week low of ₹16.55, reflecting persistent selling pres..."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs.16.76",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-falls-to-52-week-low-of-rs1676-3796872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BharatImmunolog_priceRelatedfactors_3796872.png",
        "date": "2026-01-20 15:57:12",
        "description": "Shares of Bharat Immunological & Biological Corporation Ltd have declined to a fresh 52-week low of Rs.16.76, marking a significant downturn amid broader market pressures and company-specific headwinds. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its financial health and recent performance metrics."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Hits 52-Week Low at Rs.16.76",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-hits-52-week-low-at-rs1676-3796870",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BharatImmunolog_priceRelatedfactors_3796870.png",
        "date": "2026-01-20 15:57:01",
        "description": "Bharat Immunological & Biological Corporation Ltd’s stock declined to a fresh 52-week low of Rs.16.76 on 20 Jan 2026, marking a significant downturn amid broader market weakness and sectoral pressures. The stock has underperformed its Pharmaceuticals & Biotechnology peers and the benchmark Sensex over the past year, reflecting ongoing financial and performance concerns."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3794021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BharatImmunolog_mojoScore_3794021.png",
        "date": "2026-01-19 10:10:32",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 January 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3783080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BharatImmunolog_mojoScore_3783080.png",
        "date": "2026-01-06 10:10:26",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 April 2024. However, the analysis and financial metrics presented here reflect the stock’s current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3769709",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatImmunolog_mojoScore_3769709.png",
        "date": "2025-12-25 15:12:53",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 25 December 2025, providing investors with an up-to-date view of its performance and prospects."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Stock Hits 52-Week Low at Rs.18.58",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-stock-hits-52-week-low-amidst-continued-downtrend-3751570",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatImmunolog_priceRelatedfactors_3751570.png",
        "date": "2025-12-08 13:17:33",
        "description": "Shares of Bharat Immunological & Biological Corporation touched a fresh 52-week low of Rs.18.58 today, marking a significant decline amid a broader market environment where the Sensex showed modest weakness. The stock has recorded a three-day consecutive decline, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bharat Immunolog Sees Revision in Market Assessment Amidst Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunolog-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-trends-3749851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatImmunolog_mojoScore_3749851.png",
        "date": "2025-12-06 10:10:23",
        "description": "Bharat Immunolog, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights concerns across multiple analytical parameters, signalling caution for investors amid persistent underperformance and deteriorating fundamentals."
      },
      {
        "title": "Why is Bharat Immunolog falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bharat-immunolog-fallingrising-3662777",
        "imagepath": "",
        "date": "2025-10-31 22:41:08",
        "description": "As of 31-Oct, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 20.28, which reflects a decrease of 0.31 or 1.51%. The stock has underperformed its sector by 1.06% today and has been on a downward trend for the last two days, resulting in a total drop of 3.57% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 2.31%, and it has seen a significant decline of 14.75% year-to-date, compared to a positive return of 7.42% for the benchmark Sensex. Notably, there has been a rise in investor participation, with delivery volume increasing by 141.98% against the 5-day average, suggesting some interest despite the overall negative performance.\n\nIn the broader market context, the stock's recent performance contras..."
      }
    ],
    "total": 83,
    "sid": "936506",
    "stock_news_url": "https://www.marketsmojo.com/news/bharat-immunological-biological-corporation-936506"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "07-Aug-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "29-Feb-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.",
      "source": "BSE"
    },
    {
      "caption": "Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.",
      "datetime": "13-Dec-2023",
      "details": "Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Bharat Immunological & Biological Corporation Ltd falling/rising?

2026-01-22 01:20:15

Recent Price Movement and Market Performance

The stock has experienced a notable decline over recent periods, with a one-week loss of 7.22%, significantly underperforming the Sensex’s modest 1.77% drop. Over the past month, the stock fell 8.17%, more than double the benchmark’s 3.56% decline. Year-to-date, the stock has dropped 14.90%, while the Sensex has only declined 3.89%. This trend extends over longer horizons, with the stock losing 34.88% in the last year compared to the Sensex’s 8.01% gain, and a 39.11% decline over three years against a 35.12% rise in the benchmark. The five-year performance is even more stark, with the stock plunging 74.86% while the Sensex surged 65.06%.

On 21-Jan, the stock hit a new 52-week low of ₹16.55, reflecting persistent selling pres...

Read full news article
stock-recommendationAnnouncement

Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.

07-Aug-2024 | Source : BSE

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.

Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.

29-Feb-2024 | Source : BSE

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.

Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.

13-Dec-2023 | Source : BSE

Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available